The synthetic hallucinogen, 2C-B, which has been offered in Latin American and Caribbean regions as “cocaina rosada” can result in a range of undesirable outcomes.Drugs sold as “pink copyright” could incorporate any range of drugs and additives able to triggering delicate to critical outcomes on wellbeing.Amongst the first potential risks o